Back to Annual Meeting Program
Biologic Mesh in a Contaminated Field: Infected Mesh Removal and Hernia Repair in a Single-Stage
Jeffrey Mino*, Rosebel Monteiro, Steven Rosenblatt General Surgery, Cleveland Clinic, Cleveland, OH
Purpose: High rates of recurrence and infectious complications are associated with the repair of hernias with synthetic mesh in a contaminated surgical field. Biologic mesh is believed to reduce the rates of these complications. We compared the performance of two widely available biomaterials, Permacol and Alloderm, in a single-stage procedure of infected mesh removal and hernia repair.
Methods: All patients who underwent a single-stage incisional hernia repair with replacement of an infected synthetic mesh by a biologic mesh were identified. Data retrieved included patient demographics, details of current hernia repair with biologic mesh, post-operative complications, and hernia recurrence.
Results: Forty-one incisional hernia repairs met our inclusion criteria. Alloderm was used in 21 (51.2%) cases and Permacol was utilized in 20 (48.8%) cases. Seventeen patients (41.5%) developed a recurrent hernia at a mean interval of 10.4 months from surgery. Hernias repaired with Alloderm recurred in 47.6% (10 of 21) patients, while Permacol repairs recurred in 35% (7 of 20) of cases (p=0.412). Infectious complications necessitating surgical intervention developed in 9 cases (22%). Hernias repaired using the bridging technique revealed an 87.5% recurrence rate (7 of 8), while underlay fixation of the mesh with native fascial reapproximation led to recurrence in only 31.3% of the cases (10 of 32).
Conclusion: Our results demonstrate relatively high rates of recurrence when performing a single stage ventral hernia repair in a contaminated field with biologic mesh. Permacol and Alloderm showed similar results in this series. This rate is significantly higher than typically reported in literature, likely due to longer follow-up and relatively high patient acuity, and calls into question the cost-effectiveness of the use of biologic mesh in a single stage repair for contaminated recurrent hernias vs the older approach of using a lightweight absorbable synthetic with a second-stage definitive repair. Table 1. Characteristics of patients undergoing hernia repair with biologic mesh in an infected field
| Overall | Alloderm | Permacol | p-value | N | 41 | 21 | 20 | - | Gender, Males | 39% | 30% | 48% | 0.248 | Age, years | 58.7 (11) | 56.8 (8) | 60.7 (14) | 0.094 | Mesh positioning (%underlay/inlay/onlay) | 78/20/2 | 62/33/5 | 95/5/0 | 0.037 | Length of stay, days | 6.1 (2) | 6.8 (2) | 5.4 (2) | 0.024 | Recurrenc rate | 41.5% | 47.6% | 35% | 0.412 | Interval to recurrence, months | 10.4 (7) | 9.0 (7) | 12.4 (8) | 0.370 | Duration of follow-up, months | 16.1 (15) | 17.0 (15) | 15.3 (16) | 0.790 |
Data presented as means (SD), or percentages where indicated
Table 2. Mesh positioning and recurrence rates: Permacol vs. Alloderm
| Overall | Alloderm | Permacol | N | 41 | 21 | 20 | Underlay | 32 | 13 | 19 | Recurrence (%) | 10 (31.3) | 4 (30.8) | 6 (31.6) | Inlay | 8 | 7 | 1 | Recurrence (%) | 7 (87.5) | 6 (85.7) | 1 (100) | Onlay | 1 | 1 | 0 | Recurrence (%) | 0 (0) | 0 (0) | 0 (0) |
Back to Annual Meeting Program
|